Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 49 | 2023 | 343 | 10.740 |
Why?
|
| Sleep | 22 | 2022 | 122 | 5.690 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 12 | 2022 | 58 | 5.260 |
Why?
|
| Sleep, REM | 9 | 2017 | 11 | 2.140 |
Why?
|
| Autonomic Nervous System | 5 | 2019 | 36 | 2.060 |
Why?
|
| Fear | 7 | 2022 | 234 | 1.780 |
Why?
|
| Polysomnography | 13 | 2019 | 30 | 1.670 |
Why?
|
| Urban Population | 6 | 2016 | 318 | 1.640 |
Why?
|
| Veterans | 6 | 2018 | 115 | 1.500 |
Why?
|
| Heart Rate | 6 | 2019 | 248 | 1.410 |
Why?
|
| Young Adult | 21 | 2022 | 4012 | 1.310 |
Why?
|
| Wounds and Injuries | 6 | 2015 | 166 | 1.300 |
Why?
|
| Circadian Rhythm | 4 | 2016 | 212 | 1.260 |
Why?
|
| Humans | 74 | 2023 | 34853 | 1.220 |
Why?
|
| Adult | 43 | 2022 | 11034 | 1.120 |
Why?
|
| Resilience, Psychological | 2 | 2016 | 61 | 1.010 |
Why?
|
| Stress, Psychological | 5 | 2018 | 541 | 0.990 |
Why?
|
| Male | 49 | 2023 | 18870 | 0.980 |
Why?
|
| Female | 47 | 2023 | 19873 | 0.950 |
Why?
|
| Adolescent | 20 | 2022 | 5035 | 0.870 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 165 | 0.860 |
Why?
|
| Anxiety Disorders | 5 | 2023 | 281 | 0.790 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2018 | 243 | 0.790 |
Why?
|
| Antipsychotic Agents | 5 | 2008 | 68 | 0.720 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2016 | 12 | 0.710 |
Why?
|
| Blood Pressure | 2 | 2015 | 613 | 0.670 |
Why?
|
| Sleep Paralysis | 2 | 2008 | 2 | 0.670 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 120 | 0.670 |
Why?
|
| Arousal | 2 | 2019 | 82 | 0.670 |
Why?
|
| Military Personnel | 1 | 2018 | 67 | 0.640 |
Why?
|
| Perception | 1 | 2019 | 183 | 0.630 |
Why?
|
| Residence Characteristics | 2 | 2018 | 301 | 0.620 |
Why?
|
| Darkness | 1 | 2017 | 27 | 0.600 |
Why?
|
| Hydrocortisone | 2 | 2014 | 72 | 0.600 |
Why?
|
| Emotions | 1 | 2019 | 204 | 0.580 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 38 | 0.580 |
Why?
|
| Sleep Stages | 1 | 2016 | 5 | 0.580 |
Why?
|
| Severity of Illness Index | 9 | 2016 | 608 | 0.570 |
Why?
|
| Receptors, Odorant | 1 | 2016 | 40 | 0.560 |
Why?
|
| Obesity | 2 | 2014 | 965 | 0.550 |
Why?
|
| Risperidone | 2 | 2006 | 5 | 0.540 |
Why?
|
| Combat Disorders | 2 | 2006 | 3 | 0.540 |
Why?
|
| Research Design | 4 | 2013 | 292 | 0.530 |
Why?
|
| Theta Rhythm | 1 | 2014 | 7 | 0.490 |
Why?
|
| Hypnotics and Sedatives | 2 | 2005 | 27 | 0.490 |
Why?
|
| Risk Factors | 11 | 2016 | 3414 | 0.490 |
Why?
|
| Middle Aged | 24 | 2018 | 9642 | 0.470 |
Why?
|
| Survivors | 2 | 2012 | 126 | 0.470 |
Why?
|
| Academies and Institutes | 1 | 2013 | 35 | 0.470 |
Why?
|
| Life Change Events | 6 | 2012 | 85 | 0.470 |
Why?
|
| Electrocardiography | 4 | 2018 | 154 | 0.470 |
Why?
|
| DNA Methylation | 1 | 2016 | 301 | 0.460 |
Why?
|
| Cytokines | 1 | 2017 | 569 | 0.460 |
Why?
|
| Comorbidity | 8 | 2014 | 606 | 0.460 |
Why?
|
| Minority Health | 1 | 2013 | 81 | 0.450 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2013 | 47 | 0.450 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 205 | 0.450 |
Why?
|
| Amygdala | 1 | 2013 | 110 | 0.430 |
Why?
|
| Minority Groups | 2 | 2014 | 537 | 0.430 |
Why?
|
| Weight Loss | 1 | 2013 | 124 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2014 | 233 | 0.420 |
Why?
|
| Community-Institutional Relations | 1 | 2013 | 171 | 0.410 |
Why?
|
| Time Factors | 6 | 2017 | 1681 | 0.400 |
Why?
|
| Fatigue | 1 | 2011 | 79 | 0.390 |
Why?
|
| Depressive Disorder | 3 | 2008 | 166 | 0.380 |
Why?
|
| Universities | 1 | 2013 | 363 | 0.380 |
Why?
|
| Wakefulness | 4 | 2018 | 20 | 0.360 |
Why?
|
| Sleep Deprivation | 2 | 2008 | 23 | 0.360 |
Why?
|
| Healthcare Disparities | 2 | 2013 | 446 | 0.360 |
Why?
|
| Bipolar Disorder | 2 | 2007 | 46 | 0.350 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 13 | 0.340 |
Why?
|
| Receptors, Serotonin | 1 | 2009 | 21 | 0.340 |
Why?
|
| Mental Recall | 1 | 2009 | 73 | 0.340 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 59 | 0.330 |
Why?
|
| Alleles | 1 | 2009 | 284 | 0.320 |
Why?
|
| Extinction, Psychological | 1 | 2009 | 89 | 0.310 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 2561 | 0.310 |
Why?
|
| Health Status Disparities | 1 | 2013 | 583 | 0.310 |
Why?
|
| Prevalence | 6 | 2015 | 1425 | 0.300 |
Why?
|
| Sympathetic Nervous System | 3 | 2017 | 74 | 0.290 |
Why?
|
| Dyssomnias | 1 | 2006 | 2 | 0.280 |
Why?
|
| Trauma Severity Indices | 2 | 2016 | 26 | 0.280 |
Why?
|
| District of Columbia | 3 | 2014 | 68 | 0.280 |
Why?
|
| Actigraphy | 2 | 2018 | 12 | 0.280 |
Why?
|
| Double-Blind Method | 4 | 2022 | 269 | 0.270 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 1 | 0.270 |
Why?
|
| Alcoholism | 2 | 2008 | 220 | 0.260 |
Why?
|
| Triazoles | 2 | 2022 | 85 | 0.260 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2004 | 22 | 0.240 |
Why?
|
| Prazosin | 2 | 2018 | 11 | 0.240 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 1426 | 0.240 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2009 | 94 | 0.240 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 42 | 0.240 |
Why?
|
| Temazepam | 1 | 2002 | 1 | 0.230 |
Why?
|
| Primary Health Care | 4 | 2011 | 283 | 0.220 |
Why?
|
| Saliva | 2 | 2014 | 97 | 0.220 |
Why?
|
| Accidents, Traffic | 1 | 2002 | 42 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2015 | 63 | 0.220 |
Why?
|
| Azepines | 1 | 2022 | 17 | 0.210 |
Why?
|
| Psychotherapy | 4 | 2018 | 43 | 0.210 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1056 | 0.210 |
Why?
|
| Learning | 1 | 2021 | 108 | 0.200 |
Why?
|
| United States | 8 | 2018 | 3894 | 0.190 |
Why?
|
| Mental Health | 1 | 2023 | 270 | 0.190 |
Why?
|
| Anxiety | 3 | 2023 | 705 | 0.180 |
Why?
|
| Dreams | 2 | 2018 | 7 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 375 | 0.180 |
Why?
|
| Psychometrics | 3 | 2014 | 292 | 0.180 |
Why?
|
| Poverty | 1 | 2022 | 316 | 0.180 |
Why?
|
| Afghanistan | 1 | 2018 | 7 | 0.170 |
Why?
|
| Iraq | 1 | 2018 | 6 | 0.170 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 6 | 0.170 |
Why?
|
| Health Services Research | 2 | 2013 | 133 | 0.170 |
Why?
|
| Cognition | 1 | 2022 | 373 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2012 | 628 | 0.160 |
Why?
|
| Aged | 9 | 2013 | 6448 | 0.160 |
Why?
|
| Drug Therapy, Combination | 4 | 2008 | 217 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2010 | 1349 | 0.150 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 628 | 0.150 |
Why?
|
| Implosive Therapy | 1 | 2016 | 7 | 0.150 |
Why?
|
| Medical Records | 2 | 2007 | 37 | 0.150 |
Why?
|
| Panic Disorder | 2 | 2008 | 94 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2013 | 77 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2017 | 140 | 0.140 |
Why?
|
| Prognosis | 2 | 2015 | 707 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 147 | 0.140 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 60 | 0.140 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 358 | 0.140 |
Why?
|
| Role | 1 | 2015 | 10 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2013 | 1961 | 0.140 |
Why?
|
| Vietnam | 2 | 2006 | 38 | 0.130 |
Why?
|
| Violence | 1 | 2016 | 126 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 13 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2012 | 1353 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 213 | 0.130 |
Why?
|
| Age Distribution | 1 | 2015 | 223 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2015 | 212 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.120 |
Why?
|
| Florida | 2 | 2007 | 358 | 0.120 |
Why?
|
| Vitamin D | 1 | 2016 | 176 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 198 | 0.120 |
Why?
|
| Fourier Analysis | 1 | 2014 | 40 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 490 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2013 | 33 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 34 | 0.120 |
Why?
|
| Length of Stay | 2 | 2012 | 184 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 964 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2014 | 108 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2017 | 775 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 2333 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 255 | 0.110 |
Why?
|
| Acute Disease | 2 | 2023 | 141 | 0.110 |
Why?
|
| Child | 4 | 2014 | 2875 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2015 | 1422 | 0.110 |
Why?
|
| Waist Circumference | 1 | 2013 | 82 | 0.110 |
Why?
|
| Program Development | 1 | 2013 | 225 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 894 | 0.110 |
Why?
|
| Colonic Polyps | 1 | 2013 | 67 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2015 | 727 | 0.110 |
Why?
|
| Adenoma | 1 | 2013 | 89 | 0.110 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 132 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2006 | 469 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1152 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 133 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 288 | 0.100 |
Why?
|
| Religion | 1 | 2012 | 77 | 0.100 |
Why?
|
| Inflammation | 1 | 2015 | 577 | 0.100 |
Why?
|
| Linear Models | 1 | 2011 | 253 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2012 | 183 | 0.090 |
Why?
|
| Cyclonic Storms | 1 | 2011 | 62 | 0.090 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 20 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 211 | 0.090 |
Why?
|
| Piperazines | 2 | 2008 | 109 | 0.090 |
Why?
|
| New Hampshire | 2 | 2007 | 5 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 28 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2012 | 213 | 0.090 |
Why?
|
| Medically Uninsured | 1 | 2010 | 49 | 0.090 |
Why?
|
| Dementia | 1 | 2011 | 133 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 642 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 356 | 0.090 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 2 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2010 | 99 | 0.090 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 1 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2010 | 120 | 0.090 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2008 | 2 | 0.090 |
Why?
|
| Convalescence | 1 | 2008 | 7 | 0.090 |
Why?
|
| Quinolones | 1 | 2008 | 7 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2008 | 13 | 0.090 |
Why?
|
| Aggression | 1 | 2008 | 75 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 13 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 413 | 0.080 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2008 | 22 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 29 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 102 | 0.080 |
Why?
|
| Nipecotic Acids | 1 | 2007 | 2 | 0.080 |
Why?
|
| GABA Agonists | 1 | 2007 | 21 | 0.080 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 18 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2006 | 18 | 0.070 |
Why?
|
| Genotype | 1 | 2009 | 641 | 0.070 |
Why?
|
| Domestic Violence | 1 | 2006 | 24 | 0.070 |
Why?
|
| Health Surveys | 1 | 2008 | 358 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 1007 | 0.070 |
Why?
|
| Sex Factors | 1 | 2009 | 859 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 639 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 528 | 0.070 |
Why?
|
| Registries | 1 | 2007 | 330 | 0.070 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 9 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2008 | 435 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 53 | 0.070 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sertraline | 1 | 2004 | 7 | 0.060 |
Why?
|
| Community Mental Health Centers | 1 | 2003 | 2 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2005 | 202 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 882 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 221 | 0.060 |
Why?
|
| Animals | 3 | 2015 | 14307 | 0.060 |
Why?
|
| Schizophrenic Psychology | 1 | 2002 | 17 | 0.050 |
Why?
|
| Hypertension | 1 | 2009 | 770 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2021 | 42 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 47 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2002 | 73 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 52 | 0.050 |
Why?
|
| Injury Severity Score | 2 | 2012 | 55 | 0.050 |
Why?
|
| Disease Progression | 1 | 2023 | 580 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 984 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 685 | 0.050 |
Why?
|
| Health Policy | 1 | 2002 | 149 | 0.050 |
Why?
|
| Depression | 1 | 2006 | 664 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 555 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 841 | 0.040 |
Why?
|
| Hospitalization | 1 | 2002 | 370 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 16 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 424 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2014 | 1318 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 65 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 142 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 33 | 0.030 |
Why?
|
| Women | 1 | 2012 | 26 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2012 | 11 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2012 | 19 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2012 | 75 | 0.030 |
Why?
|
| New Orleans | 1 | 2011 | 11 | 0.030 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 13 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2012 | 71 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2012 | 429 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 393 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 187 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 20 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2011 | 108 | 0.020 |
Why?
|
| Benztropine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 31 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 288 | 0.020 |
Why?
|
| Psychology | 1 | 2008 | 32 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 490 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 459 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 570 | 0.020 |
Why?
|
| Demography | 1 | 2008 | 167 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2007 | 41 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 102 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 747 | 0.020 |
Why?
|
| REM Sleep Parasomnias | 1 | 2006 | 1 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1014 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2006 | 32 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2005 | 37 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 114 | 0.020 |
Why?
|
| Cause of Death | 1 | 2005 | 154 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 423 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 901 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 427 | 0.010 |
Why?
|
| Critical Pathways | 1 | 2002 | 15 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2002 | 29 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 124 | 0.010 |
Why?
|
| Medicaid | 1 | 2002 | 102 | 0.010 |
Why?
|